Manufacturer record

Rhydburg Pharmaceuticals Ltd: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

7 batches manufactured by Rhydburg Pharmaceuticals Ltd (Uttarakhand) were declared Not of Standard Quality between October 2019 and April 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

7 records linked to Rhydburg Pharmaceuticals Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
7Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Oct 2019 to Apr 2025

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

7
NSQ batches since 2019
7
Products affected
Dissolution
Most common failure
Apr 2025
Latest alert

Flagged batches per year

2019 · 12020 · 32021 · 12022 · 12025 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Betamethasone Valerate Cream IP E4062Mfg 2024-02 · Exp 2026-01 Sample does not conform to IP specification for Betamethasone Valerate Cream with respect to the content of Betamethasone in Betamethasone Valerate.Other DTL MaduraiState lab Apr 2025
MONTELUKAST TABLETS IP T2203068Mfg 2022-03 · Exp 2024-02 Related SubstancesRelated substances RDTL ChandigarhCDSCO lab Oct 2022
TRANEXAMIC ACID TABLETS IP T2002047Mfg 2020-02 · Exp 2022-01 Related SubstancesRelated substances RDTL ChandigarhCDSCO lab Apr 2021
Nefidinol Retard- 10 Tablets T8120289Mfg 2018-12 · Exp 2020-11 Non-compliance with physical description of tablets and unfit for human consumptionDescription RDTL GuwahatiState lab Jul 2020
Clopidogrel & Aspirin Tablets 75/75 mg T8090229Mfg 2018-09 · Exp 2020-08 Dissolution of AspirinDissolution CDTL MumbaiCDSCO lab Apr 2020
Albendazole Tablets I.P. (REBEN) T9030099Mfg 2019-03 · Exp 2021-02 DissolutionDissolution RDTL GuwahatiState lab Mar 2020
Clindamycin Phosphate Gel USP 1% w/w 8073Mfg 2018-06 · Exp 2020-05 AssayAssay RDTL ChandigarhCDSCO lab Oct 2019

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.